. Author manuscript; available in PMC: 2019 Dec 12.

Published in final edited form as: J Clin Psychiatry. 2018 Jan-Feb;79(1):17m11585. doi: 10.4088/JCP.17m11585

Table 1:

Baseline clinical characteristics of the study participants

	Relamorelin (n=10)	Placebo (n=12)	p-value
Age (years)	28.9 ± 2.4	28.9 ± 1.9	0.99
% Ideal body weight	79.9 ± 1.5	81.0 ± 2.1	0.67
Weight (kg)	48.1 ± 1.5	48.9 ± 1.8	0.73
Height (cm)	165.2 ± 2.3	165.3 ± 1.9	0.97
BMI (kg/m²)	17.6 ± 0.4	17.8 ± 0.4	0.58
Duration of anorexia nervosa (years)	13.2 ± 2.2	14.8 ± 2.2	0.60
Gastric emptying time (minutes)^*	89 [69.5, 110.8]	85.5 [74.0, 125.8]	0.60
Resting energy expenditure (kcals/day)	1040 ± 40	1055 ± 53	0.83
Beck Depression Inventory-2 score	15.2 ± 2.8	12.3 ± 2.1	0.41
Visual Analog Scale – Hungry^*	6.3 [2.2, 8.1]	3.0 [1.0, 5.5]	0.15
Total ghrelin (pg/ml)^*	878 [722, 1191]	1131 [825, 1263]	0.34
Acylated ghrelin (pg/ml)^*	162 [118, 293]	140 [52, 366]	0.65
Desacyl ghrelin (pg/ml)^*	422 [225, 678]	444 [318, 599]	0.87
IGF-1 (ng/ml)	156 ± 10	171 ± 14	0.39
Serum glucose (mg/dL)	77.8 ± 2.3	83.1 ± 2.4	0.13

Mean ± SEM

median [interquartile range]